CIR at 5 years after the end of induction therapy, by patient characteristics
| . | 5-year CIR (95% CI) . | P* . |
|---|---|---|
| All patients | 23.4 (17.1-31.8) | |
| Body fat category | ||
| Underweight/normal | 11.2 (5.3-23.8) | .029 |
| Overweight/obese | 31.6 (22.7-43.8) | |
| Age at diagnosis | ||
| ≤ 40 years | 18.7 (11.2-31.3) | .34 |
| > 40 years | 27.8 (18.9-40.8) | |
| Sex | ||
| Male | 32.2 (22.2-46.7) | .079 |
| Female | 16.4 (9.7-27.6) | |
| French-American-British subtype | ||
| Typical | 22 (15.4-31.4) | .16 |
| Variant | 30.4 (16.4-56.5) | |
| PML/RARα | ||
| BCR1-2 | 16.1 (9.6-27.2) | .027 |
| BCR3 | 32.6 (22.5-47.2) | |
| WBC | ||
| ≤ 10 × 109/L | 24.4 (17.2-34.6) | .99 |
| > 10 × 109/L | 20.6 (10.6-39.8) | |
| Platelets | ||
| ≤ 40 | 21.7 (14.7-32) | .70 |
| > 40 | 27.4 (16.4-45.5) | |
| Hemoglobin | ||
| ≤ 10 g/dL | 26 (18.1-37.3) | .21 |
| > 10 g/dL | 18.7 (10.4-33.8) | |
| Sanz risk score | ||
| Low | 24.7 (13.5-45.2) | .94 |
| Intermediate | 25.2 (16.5-38.7) | |
| High | 18.9 (9.7-36.9) | |
| Differentiation syndrome | ||
| No | 22.8 (16.3-32.1) | .98 |
| Yes | 26.1 (12.2-55.7) |
| . | 5-year CIR (95% CI) . | P* . |
|---|---|---|
| All patients | 23.4 (17.1-31.8) | |
| Body fat category | ||
| Underweight/normal | 11.2 (5.3-23.8) | .029 |
| Overweight/obese | 31.6 (22.7-43.8) | |
| Age at diagnosis | ||
| ≤ 40 years | 18.7 (11.2-31.3) | .34 |
| > 40 years | 27.8 (18.9-40.8) | |
| Sex | ||
| Male | 32.2 (22.2-46.7) | .079 |
| Female | 16.4 (9.7-27.6) | |
| French-American-British subtype | ||
| Typical | 22 (15.4-31.4) | .16 |
| Variant | 30.4 (16.4-56.5) | |
| PML/RARα | ||
| BCR1-2 | 16.1 (9.6-27.2) | .027 |
| BCR3 | 32.6 (22.5-47.2) | |
| WBC | ||
| ≤ 10 × 109/L | 24.4 (17.2-34.6) | .99 |
| > 10 × 109/L | 20.6 (10.6-39.8) | |
| Platelets | ||
| ≤ 40 | 21.7 (14.7-32) | .70 |
| > 40 | 27.4 (16.4-45.5) | |
| Hemoglobin | ||
| ≤ 10 g/dL | 26 (18.1-37.3) | .21 |
| > 10 g/dL | 18.7 (10.4-33.8) | |
| Sanz risk score | ||
| Low | 24.7 (13.5-45.2) | .94 |
| Intermediate | 25.2 (16.5-38.7) | |
| High | 18.9 (9.7-36.9) | |
| Differentiation syndrome | ||
| No | 22.8 (16.3-32.1) | .98 |
| Yes | 26.1 (12.2-55.7) |
Gray test, comparing cumulative incidences among categories.